CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 185 filers reported holding CYTOKINETICS INC in Q4 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $57,000 | -90.9% | 1,568 | -88.6% | 0.01% | -90.2% |
| Q4 2021 | $626,000 | -20.5% | 13,748 | -37.6% | 0.05% | -12.1% |
| Q3 2021 | $787,000 | +1688.6% | 22,036 | +1059.8% | 0.06% | +1350.0% |
| Q1 2021 | $44,000 | +29.4% | 1,900 | +18.8% | 0.00% | 0.0% |
| Q3 2020 | $34,000 | +209.1% | 1,600 | +220.0% | 0.00% | +300.0% |
| Q2 2020 | $11,000 | +57.1% | 500 | -28.6% | 0.00% | 0.0% |
| Q2 2019 | $7,000 | -66.7% | 700 | -72.8% | 0.00% | -50.0% |
| Q4 2017 | $21,000 | -62.5% | 2,577 | -45.3% | 0.00% | -60.0% |
| Q2 2017 | $56,000 | -42.9% | 4,708 | -50.0% | 0.01% | -70.6% |
| Q4 2015 | $98,000 | – | 9,419 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |